Robert Newton
1986–2025 年に発表
- 163
- 論文数
- 20,820
- 被引用数
- 90
- h 指数
- 157
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine60.1%
- Biochemistry, Genetics and Molecular Biology19.5%
- Immunology and Microbiology8.3%
- Neuroscience7.2%
- Computer Science0.8%
- Chemistry0.7%
- その他3.4%
トピック
- Viral-associated cancers and disorders3.2%
- Cancer Immunotherapy and Biomarkers2.5%
- Immune Cell Function and Interaction2.2%
- Tryptophan and brain disorders2%
- Cytokine Signaling Pathways and Interactions1.9%
- Asthma and respiratory diseases1.8%
- その他86.4%
共著者
- Peter J. Barnes20
- Peggy Scherle17
- Valerie Beral12
- Timothy C. Burn11
- Freddy Sitas10
- Janet Seeley10
- Maryanne Covington10
- Richard Leigh10
- Denise Whitby9
- Neil S. Holden9
- Carl P. Decicco8
- Ian M. Adcock8
- Jordan S. Fridman8
- Steven Friedman8
- Gengjie Yang7
- Gershim Asiki7
- Kris Vaddi7
- Mark A. Giembycz7
- Rui‐Qin Liu7
- Xiangdong Liu7
- Chantal Babb de Villiers6
- Christopher G. Mathew6
- Debbie Bradshaw6
- Delphine Casabonne6
全論文
- Clinicogenomic Analysis of FGFR2 -Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib
著者: Ian M. Silverman, Antoine Hollebecque, Luc Friboulet, Sherry Owens, Robert Newton, Hui‐Ling Zhen, Luis Féliz, Camilla Zecchetto, Davide Melisi, Timothy C. Burn - Cancer Discovery 2020 被引用: 284
- Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
著者: Xiangdong Liu, Niu Shin, Holly K. Koblish, Gengjie Yang, Qian Wang, Kathy Wang, Lynn Leffet, Michael Hansbury, Beth Ann Thomas, Mark Rupar, Paul Waeltz, Kevin Bowman, Padmaja Polam, Richard Sparks, Eddy W. Yue, Yanlong Li, Richard Wynn, Jordan S. Fridman, Timothy C. Burn, Andrew P. Combs, Robert Newton, Peggy Scherle - Blood 2010 被引用: 559
- Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
著者: Stefani Spranger, Holly K. Koblish, Brendan Horton, Peggy Scherle, Robert Newton, Thomas F. Gajewski - Journal for ImmunoTherapy of Cancer 2014 被引用: 545
- First-in-Human Phase I Study of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase-1 Epacadostat (INCB024360) in Patients with Advanced Solid Malignancies
著者: Gregory L. Beatty, Peter J. O’Dwyer, Jason Clark, Jack Shi, Kevin Bowman, Peggy Scherle, Robert Newton, Richard Schaub, Janet Maleski, Lance Leopold, Thomas F. Gajewski - Clinical Cancer Research 2017 被引用: 318
- Selective Inhibition of JAK1 and JAK2 Is Efficacious in Rodent Models of Arthritis: Preclinical Characterization of INCB028050
著者: Jordan S. Fridman, Peggy Scherle, Robert J. Collins, Timothy C. Burn, Yanlong Li, Jun Li, Maryanne Covington, Beth Ann Thomas, Paul Collier, Margaret Favata, Xiaoming Wen, Jack Shi, Ryan McGee, Patrick J. Haley, Stacey Shepard, James D. Rodgers, Swamy Yeleswaram, Greg Hollis, Robert Newton, Brian Metcalf, Steven Friedman, Kris Vaddi - The Journal of Immunology 2010 被引用: 463
- Childhood cancer: Estimating regional and global incidence
著者: W. Thomas Johnston, Friederike Erdmann, Robert Newton, Eva Steliarova‐Foucher, Joachim Schüz, Eve Roman - Cancer Epidemiology 2020 被引用: 194
- Burkitt's lymphoma
著者: Elizabeth Molyneux, Rosemary Rochford, Beverly E. Griffin, Robert Newton, Graham Jackson, Menon Geetha, Christine J. Harrison, Trijn Israëls, Simon Bailey - The Lancet 2012 被引用: 604
- The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells
著者: Caroline Jochéms, Massimo Fantini, Romaine I. Fernando, Anna Kwilas, Renee N. Donahue, Lauren M. Lepone, Italia Grenga, Young‐Seung Kim, Martin W. Brechbiel, James L. Gulley, Ravi A. Madan, Christopher R. Heery, James W. Hodge, Robert Newton, Jeffrey Schlom, Kwong Y. Tsang - Oncotarget 2016 被引用: 142
- Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study
著者: June Fabian, Robert Kalyesubula, Joseph Mkandawire, Christian Holm Hansen, Dorothea Nitsch, Eustasius Musenge, Wisdom P. Nakanga, Josephine E. Prynn, Gavin Dreyer, Tracy Snyman, Billy Ssebunnya, Michèle Ramsay, Liam Smeeth, Stephen Tollman, Saraladevi Naicker, Amelia C. Crampin, Robert Newton, Jaya A. George, Laurie A. Tomlinson, Louis Banda, Steven Bello, Keith Branson, Christina Chisambo, Odala Chithodwe, Charity Kanyenda, Cynthia Katundu, Noel Kayange, Marriot Kayolo, Veronica Kuchipanga, Dorothy Makoka Kyumba, Adrian Malunga, Beatson Mvula, Elisah Mweso, Efrida Mwiba, Lydia Ngwira, Lawrence Nkhwazi, Maureen Thindwa, Itayi Adams, K O Barrow, Claudia Beltramo, C Bouter, Geoffrey Candy, Shingirai Chipungu, Tafadzwa Chitagu, Phumzile Dlamini, Xavier Gomez Olive Casas, Mwawi Gondwe, Pearl Gumede, Chodziwadziwa Kabudula, Brenda Kagodora, Kathleen Kahn, Lungile Khambule, Bongekile Khoza, Dorcus Khoza, Simon Khoza, Weekend Khoza, Jonathan Levin, Dorcas Lesolang, Melody Mabuza, Heather Maher, Nontsikeleko Mahime, Willy Malupi, Gontse Maphatahanyi, Nonhlanhla Mashaba, Gift Mathebula, Busisiwe Mayindi, Brian Mdaka, Memory Mhembere, Mevian Mkansi, Rrhandzu Mnisi, Vusi Mnisi, Conrad Mogane, Tshepiso Mokoena, Walter Ndlovu, Zandy Ndlovu, Fortunate Ngobeni, Khanyisile Ngobeni, Nyiko Ngobeni, Tsakani Ngobeni, Ngoni Ngwarai, Doreen Nkuna, Median Ntimane, Terrence Ntimane, Obed Nxumalo, Daniel Ohene‐Kwofie, Florah Sihlangu, Bianca Silubane, Cassandra Claire Soo, Jeffrey Tibane, Rhian Twine, Surprise Ubisi, Mboyo-Di-Tamba Vangu, Alisha N. Wade, Floidy Wafawanaka, Gershim Asiki, Dominic Bukenya, Innocent Erone, Grace Tumwekase, Elizabeth Kabunga, Ayoub Kakande ほか 17 名 - The Lancet Global Health 2022 被引用: 89
- Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era
著者: Anthony N. Gerber, Robert Newton, Sarah K. Sasse - Journal of Biological Chemistry 2021 被引用: 67
- A Novel Kinase Inhibitor, INCB28060, Blocks c-MET–Dependent Signaling, Neoplastic Activities, and Cross-Talk with EGFR and HER-3
著者: Xiangdong Liu, Qian Wang, Gengjie Yang, Cindy Marando, Holly K. Koblish, Leslie Hall, Jordan S. Fridman, Elham Behshad, Richard Wynn, Yu Li, Jason Boer, Sharon Diamond, Chunhong He, Meizhong Xu, Jin‐Cong Zhuo, Wenqing Yao, Robert Newton, Peggy Scherle - Clinical Cancer Research 2011 被引用: 274
- A randomized, double-blind, placebo-controlled, dose-escalation study of the safety and efficacy of INCB039110, an oral janus kinase 1 inhibitor, in patients with stable, chronic plaque psoriasis
著者: Robert Bissonnette, Monica Luchi, Rosanne Fidelus-Gort, Shawnta Jackson, Haifeng Zhang, Robert Flores, Robert Newton, Peggy Scherle, Swamy Yeleswaram, Xuejun Chen, Alan Menter - Journal of Dermatological Treatment 2016 被引用: 84
- A randomised, open-label, phase 2 study of the IDO1 inhibitor epacadostat (INCB024360) versus tamoxifen as therapy for biochemically recurrent (CA-125 relapse)–only epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube cancer
著者: Rebecca Kristeleit, Ірина Давиденко, Vadim Shirinkin, Fatima El-Khouly, Igor Bondarenko, Michael J. Goodheart, В. А. Горбунова, C A Penning, Jack Shi, Xiangdong Liu, Robert Newton, Yufan Zhao, Janet Maleski, Lance Leopold, Russell J. Schilder - Gynecologic Oncology 2017 被引用: 101
- Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancer
著者: Bin-Bing Zhou, Michael Peyton, Biao He, Changnian Liu, Luc Girard, Eian Caudler, Yvonne Lo, Frédéric Baribaud, Iwao Mikami, Noemı́ Reguart, Gengjie Yang, Yanlong Li, Wenqing Yao, Kris Vaddi, Adi F. Gazdar, Steven Friedman, David M. Jablons, Robert Newton, Jordan S. Fridman, John D. Minna, Peggy Scherle - Cancer Cell 2006 被引用: 375
- Pediatric Malignancies, Treatment Outcomes and Abandonment of Pediatric Cancer Treatment in Zambia
著者: Jeremy S. Slone, Catherine Chunda‐Liyoka, Marta Sánchez Pérez, Nora Mutalima, Robert Newton, Chifumbe Chintu, Chipepo Kankasa, James Chipeta, Douglas C. Heimburger, Sten H. Vermund, Debra L. Friedman - PLoS ONE 2014 被引用: 106
- Preclinical characterization of itacitinib (INCB039110), a novel selective inhibitor of JAK1, for the treatment of inflammatory diseases
著者: Maryanne Covington, Xin He, Monika Scuron, Jun Li, Robert J. Collins, Ashish Juvekar, Niu Shin, Margaret Favata, Karen Gallagher, Sarala Sarah, Chu‐Biao Xue, Michael T. Peel, Krista Burke, Julian Oliver, Brittany Fay, Wenqing Yao, Taisheng Huang, Peggy Scherle, Sharon Diamond, Robert Newton, Yan Zhang, Paul Smith - European Journal of Pharmacology 2020 被引用: 47
- Usefulness of high‐risk HPV early oncoprotein (E6 and E7) serological markers in the detection of cervical cancer: A systematic review and meta‐analysis
著者: Mwiza Gideon Singini, Elvira Singh, Debbie Bradshaw, Thendo Ramaliba, Wenlong Carl Chen, Melitah Motlhale, Abram Bunya Kamiza, Chantal Babb de Villiers, Mazvita Muchengeti, Christopher G. Mathew, Robert Newton, Noemi Bender, Tim Waterboer, Freddy Sitas - Journal of Medical Virology 2022 被引用: 24
- Synergistic Inhibition with a Dual Epidermal Growth Factor Receptor/HER-2/neu Tyrosine Kinase Inhibitor and a Disintegrin and Metalloprotease Inhibitor
著者: Lois Witters, Peggy Scherle, Steven Friedman, Jordan S. Fridman, Eian Caulder, Robert Newton, Allan Lipton - Cancer Research 2008 被引用: 116
- Age patterns of HIV incidence in eastern and southern Africa: a modelling analysis of observational population-based cohort studies
著者: Kathryn Risher, Anne Cori, Georges Reniers, Milly Marston, Clara Calvert, Amelia C. Crampin, Tawanda Dadirai, Albert Dube, Simon Gregson, Kobus Herbst, Tom Lutalo, Louisa Moorhouse, Baltazar Mtenga, Dorean Nabukalu, Robert Newton, Alison Price, Malebogo Tlhajoane, Jim Todd, Keith Tomlin, Mark Urassa, Alain Vandormael, Christophe Fraser, Emma Slaymaker, Jeffrey W. Eaton - The Lancet HIV 2021 被引用: 90
- Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis
著者: Anna McNaughton, José Lourenço, Phillip Armand Bester, Jolynne Mokaya, Sheila Lumley, Uri Obolski, Dónall Forde, Tongai Maponga, Kenneth Katumba, Dominique Goedhals, Sunetra Gupta, Janet Seeley, Robert Newton, Ponsiano Ocama, Philippa C. Matthews - PLoS Medicine 2020 被引用: 77
- Interplay between nuclear factor-κB, p38 MAPK, and glucocorticoid receptor signaling synergistically induces functional TLR2 in lung epithelial cells
著者: Akanksha Bansal, Mahmoud Mostafa, Cora Kooi, Sarah K. Sasse, Aubrey N. Michi, Suharsh Shah, Richard Leigh, Anthony N. Gerber, Robert Newton - Journal of Biological Chemistry 2022 被引用: 23
- Molecular mechanisms of glucocorticoid action: what is important?
著者: Robert Newton - Thorax 2000 被引用: 513
- Cloning and Characterization of ADAMTS11 , an Aggrecanase from the ADAMTS Family
著者: Ilgar Abbaszade, Rui‐Qin Liu, Fude Yang, Stuart A. Rosenfeld, O.Harold Ross, John R. Link, Dawn M. Ellis, Micky D. Tortorella, Michael A. Pratta, Jeannine M. Hollis, Richard Wynn, Jodie L. Duke, Henry J. George, Milton C. Hillman, Kathleen Murphy, Barbara H. Wiswall, Robert A. Copeland, Carl P. Decicco, R. Brückner, Hideaki Nagase, Yoshifumi Itoh, Robert Newton, Ronald L. Magolda, James M. Trzăskos, Gregory Hollis, Elizabeth C. Arner, Timothy C. Burn - Journal of Biological Chemistry 1999 被引用: 489
- Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms
著者: Louise Donnelly, Robert Newton, Gina E. Kennedy, Peter Fenwick, Rachel H. F. Leung, Kazuhiro Ito, Richard Russell, Peter J. Barnes - American Journal of Physiology-Lung Cellular and Molecular Physiology 2004 被引用: 360
